Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bridging the treatment gap.

S C Smith1

  • 1Division of Cardiology, University of North Carolina Cardiovascular Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7075, USA.

The American Journal of Cardiology
|June 20, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genomic landscape of familial glioma.

Science advances·2023
Same author

Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.

The European respiratory journal·2022
Same author

Proxy reporting of health-related quality of life for people with dementia: a psychometric solution.

Health and quality of life outcomes·2020
Same author

Psoas and Paraspinous Muscle Measurements on Computed Tomography Predict Mortality in European Americans with Type 2 Diabetes Mellitus.

The Journal of frailty & aging·2019
Same author

Synthesis, optical properties and theoretical modelling of discrete emitting states in doped silicon nanocrystals for bioimaging.

Nanoscale·2018
Same author

Fermi Level Determination for Charged Systems via Recursive Density of States Integration.

The journal of physical chemistry letters·2018
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Cardiovascular disease (CVD) is a leading cause of death. Making cholesterol-lowering statins available over-the-counter (OTC) could improve treatment rates and reduce heart disease risk for many patients.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of death and disability in the U.S.
  • Hypercholesterolemia, a major risk factor for CVD, is significantly undertreated.
  • Lowering low-density lipoprotein (LDL) cholesterol by 25-35% demonstrably reduces morbidity and mortality.

Purpose of the Study:

  • To evaluate the potential benefits of increased availability of cholesterol-lowering therapies.
  • To explore consumer interest in over-the-counter (OTC) statin products.
  • To address suboptimal outcomes in CVD prevention due to undertreatment.

Main Methods:

  • Analysis of current prescribing practices and treatment guidelines for cholesterol-lowering agents.
  • Review of consumer surveys regarding interest in OTC cholesterol-lowering products.

Related Experiment Videos

  • Assessment of the efficacy, safety, and accessibility of statin therapy.

    • Main Results:

    • Current treatment rates for hypercholesterolemia remain low, impacting CVD prevention outcomes.
    • A significant portion of patients with high cholesterol express interest in OTC statin options.
    • Wider access to lipid-lowering agents could improve patient outcomes.

    Conclusions:

    • Increased availability of cholesterol-lowering therapies, potentially via OTC statins, could enhance CVD prevention.
    • Proposed advantages of OTC statins include proven efficacy, safety, and dose consistency.
    • Changes in prescribing practices and expanded access are needed to improve population-level cardiovascular health.